Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders

The class and subclass distribution of an antibody response may give insight into the stimulating mechanism and likely effector functions. IgA, IgG and IgM anlicardiolipin antibodies (aCL) were quantified in a consecutive series of 200 samples sent to an autoimmune serology laboratory to determine the relationships between aCL responses of each of these antibody classes and, in particular, whether there was any utility in the measurement of IgA aCL. Positive results for one of the three aCL isotypes were found in 105 samples (53%). and in 41 samples IgA aCL was detected (21%). However, amongst these unselected samples, little additional information was obtained by measurement of IgA aCL, which was found in conjunction with IgM or IgG aCL in all but five samples, and in these the isolated elevation of IgA aCL was only slight, and showed no disease specificity. The levels of each of the four IgG subclasses of aCL were measured in a subgroup of serum samples from 28 patients with autoimmune disease and from 29 patients with syphilis. Amongst the SLE patients IgGl and lgG3 aCL were the predominant IgG subclasses, consistent with an antigen‐driven. T cell‐dependent antibody response. However, a subgroup of eight of the autoimmune subjects had predominant elevation of IgG2 aCL, possibly implying a role for T cell‐independent antibody production to cardiolipin. Amongst the syphilis patients IgG I and IgG3 aCL were also the predominant subclasses of aCL but lgG4 aCL were also detected in the majority of subjects, consistent with prolonged antigenic stimulation.

[1]  M. Walport,et al.  Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus. , 1992, British journal of rheumatology.

[2]  B. Roussel,et al.  Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. , 1991, Clinical and experimental immunology.

[3]  S. Pierangeli,et al.  The anticardiolipin ELISA test , 1991 .

[4]  M. Lockshin,et al.  Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. , 1990, The Journal of rheumatology.

[5]  J. Versalovic,et al.  Immunoglobulin class and subclass restriction of autoimmune responses in secondary syphilis , 1990, Clinical and experimental immunology.

[6]  M. Walport,et al.  Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis , 1990, Clinical and experimental immunology.

[7]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[8]  N. Rote,et al.  IgG1 and IgG2 are the predominant subclasses of antiphospholipid antibody in women with the lupus anticoagulant. , 1990, Clinical immunology and immunopathology.

[9]  J. Sánchez-Guerrero,et al.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients , 1989, Medicine.

[10]  J. Banga,et al.  Affinity Purification of IgG Subclasses and the Distribution of Thyroid Auto‐Antibody Reactivity in Hashimoto's Thyroiditis , 1989, Scandinavian journal of immunology.

[11]  D. Alarcón-Segovia,et al.  Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. , 1989, The Journal of rheumatology.

[12]  M. Walport,et al.  Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. , 1989, Annals of the rheumatic diseases.

[13]  N. Simonian,et al.  Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. , 1989, Stroke.

[14]  R. Pumphrey,et al.  Anticardiolipin antibodies in systemic lupus erythematous. , 1989, Annals of the rheumatic diseases.

[15]  K. Takabayashi,et al.  IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus. , 1988, Journal of Rheumatology.

[16]  K. Kalunian,et al.  Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. , 1988, The American journal of medicine.

[17]  R. Hughes,et al.  Severe Guillain-Barré syndrome: An association with IgA anti-cardiolipin antibody in a series of 92 patients , 1988, Journal of Neuroimmunology.

[18]  M. Walport,et al.  Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. , 1988, The Quarterly journal of medicine.

[19]  P. Holt,et al.  An IgG subclass imbalance in connective tissue disease. , 1988, Annals of the rheumatic diseases.

[20]  T. Winkler,et al.  Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. , 1988, Clinical and experimental immunology.

[21]  D. Alarcón-Segovia,et al.  Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. , 1988, The Journal of rheumatology.

[22]  G. Hughes,et al.  IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. , 1988, Annals of the Rheumatic Diseases.

[23]  B. Plikaytis,et al.  Two-site immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full-term. , 1988, Journal of immunological methods.

[24]  G. Hughes,et al.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.

[25]  A. Weetman,et al.  The IgG subclass distribution of thyroid autoantibodies. , 1986, Immunology letters.

[26]  G. Hughes,et al.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. , 1986, Archives of internal medicine.

[27]  E. Chan,et al.  IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. , 1986, Journal of immunology.

[28]  O. Vaarala,et al.  Anticardiolipin response in acute infections. , 1986, Clinical immunology and immunopathology.

[29]  T. Bentley,et al.  Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. , 1992, Immunology letters.

[30]  J. Mccrea,et al.  Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. , 1985, Clinical and experimental immunology.

[31]  R. Eisenberg,et al.  Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. , 1985, The Journal of clinical investigation.

[32]  R. Jefferis,et al.  IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases. , 1984, Immunology.

[33]  C. Black,et al.  Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. , 1984, Hybridoma.

[34]  P. Schur,et al.  The γG subclass of antinuclear and antinucleic acid antibodies , 1972 .